相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risperidone long-acting injection: a review of its long term safety and efficacy
Michael Rainer
Neuropsychiatric Disease and Treatment (2011)
Low atazanavir concentrations in cerebrospinal fluid
Brookie M. Best et al.
AIDS (2009)
The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research
Lavanya Varatharajan et al.
ANTIVIRAL RESEARCH (2009)
Effect of Poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as Coating Agent on the Opsonization, Phagocytosis, and Pharmacokinetics of Biodegradable Nanoparticles
Genevieve Gaucher et al.
BIOMACROMOLECULES (2009)
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
Lieven Baert et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Risperidone Long-Acting Injection: A Prospective 3-Year Analysis of Its Use in Clinical Practice
David M. Taylor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS
Huanyu Dou et al.
JOURNAL OF IMMUNOLOGY (2009)
Zidovudine-Loaded PLA and PLA-PEG Blend Nanoparticles: Influence of Polymer Type on Phagocytic Uptake by Polymorphonuclear Cells
Rubiana Mara Mainardes et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles
Arnaud Beduneau et al.
PLOS ONE (2009)
Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles
Shilpa Sant et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2008)
The promise and perils of CNS drug delivery: A video debate
Howard E. Gendelman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery
Sanjay K. Jain et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier
Anathbandhu Chaudhuri et al.
BLOOD (2008)
HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction
Anathbandhu Chaudhuri et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Nanomedicine in the diagnosis and therapy of neuro degenerative disorders
A. V. Kabanov et al.
PROGRESS IN POLYMER SCIENCE (2007)
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human nomocyte-derived macrophages
Huanyu Dou et al.
VIROLOGY (2007)
Pharmacokinetic interactions between buprenorphine and antiretroviral medications
R. Douglas Bruce et al.
CLINICAL INFECTIOUS DISEASES (2006)
Squalenoyl nanomedicines as potential therapeutics
Patrick Couvreur et al.
NANO LETTERS (2006)
Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery
Santhi Gorantla et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Huanyu Dou et al.
BLOOD (2006)
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake
A. Vonarbourg et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
Jeffrey D. Kingsley et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression
Susan Swindells et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice
RD Bruce et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-Infected people treated with highly active Antiretroviral therapy - Evidence from the Italian Cohort of Antiretroviral-Naive Patients Study
R Murri et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Appearance-related side effects of HIV-1 treatment
T Hawkins
AIDS PATIENT CARE AND STDS (2006)
Cross-linked polymeric nanogel formulations of 5′-triphosphates of nucleoside analogues:: Role of the cellular membrane in drug release
Serguei V. Vinogradov et al.
MOLECULAR PHARMACEUTICS (2005)
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GIGHAART ANRS 097)
C Delaugerre et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethaerylate-sulfopropylmethacrylate copolymer nanoparticles
YC Kuo
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines
MJ Schnell et al.
JOURNAL OF NEUROVIROLOGY (2005)
Antiretroviral compounds: Mechanisms underlying failure of HAART to eradicate HIV-1
M Shehu-Xhilaga et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence
L Alos et al.
MODERN PATHOLOGY (2005)
Nanosuspensions in drug delivery
BE Rabinow
NATURE REVIEWS DRUG DISCOVERY (2004)
Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients
X Duval et al.
HIV MEDICINE (2004)
Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Intramuscular preparations of antipsychotics - Uses and relevance in clinical practice
AC Altamura et al.
DRUGS (2003)
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay et al.
LANCET (2001)
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
DL Paterson et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
